Tzivelekis S, Orange J, Poulos C, Meckley LM, Peay H, Sutphin J, Hernandez-Trujillo VP, Wasserman RL. Development of a novel shared decision making aid for primary immunodeficiency diseases. Immunotherapy. 2023 Jun;15(9):647-56. doi: 10.2217/imt-2022-0193
Anderson-Smits C, Park M, Bell J, Mitchell S, Hartley L, Hawe E. Subcutaneous immunoglobulin use in immunoglobulin-naïve patients with primary immunodeficiency: a systematic review. Immunotherapy. 2022 Apr;14(5):373-87. doi: 10.2217/imt-2021-0265
Smith EP, Witherspoon DP, Bhargava S, Bermudez JM. Cultural values and behavior among African American and European American children. J Child Fam Stud. 2019 May 1;28:1236-49.
Ferrer P, Ballarín E, Sabate M, Laporte JR, Schoonen M, Rottenkolber M, Fortuny J, Hasford J, Tatt I, Ibanez L. Sources of European drug consumption data at a country level. Int J Public Health. 2014 Oct;59(5):877-87. doi: 10.1007/s00038-014-0564-8
Foraster M. Is it traffic-related air pollution or road traffic noise, or both? key questions not yet settled!. Int J Public Health. 2013 Oct;58(5):647-8. doi: 10.1007/s00038-013-0500-3
Foraster M. Editorial - Is it traffic-related air pollution or road traffic noise, or both? Key questions not yet settled!. Int J Public Health. 2013 Oct;58(5):647-8. doi: 10.1007/s00038-013-0500-3
Casas L, Zock JP, Carsin AE, Fernandez-Somoano A, Esplugues A, Santa-Marina L, Tardon A, Ballester F, Basterrechea M, Sunyer J. The use of household cleaning products during pregnancy and lower respiratory tract infections and wheezing during early life. Int J Public Health. 2013 Oct;58(5):757-64. doi: 10.1007/s00038-012-0417-2
Manga N, Duffy JC, Rowe PH, Cronin MTD. A hierarchical QSAR model for urinary excretion of drugs in humans as a predictive tool for biotransformation. QSAR Comb Sci. 2003 Apr 17;22(2):263-73. doi: 10.1002/qsar.200390021
Bonfill X, Rivero E, Moreno C, Rué M. Changes in cancer mortality in Catalonia and Spain (1975-77 and 1987-89). A comparison with other European countries. Eur J Cancer Prev. 1995 Dec;4(6):453-8.